The new Bausch and Lomb Akreos MICS lens, already on the market in other countries, is now available for U.S. cataract patients. The lens can be inserted through a tiny, 1.8mm incision, for better wound sealability, reduction in below-the-surface cell loss and reduction in surgery-caused astigmatism, according to the company. The Centers for Medicare and Medicaid Services granted the New Technology Intraocular Lens designation to the lens for its design that reduces spherical aberration.